The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Antidepressants for depressed elderly
Open accessAbstract
BACKGROUND: Depression is a relatively common experience in older adults. The syndrome is associated with considerable distress, morbidity and service commitment. Approximately two thirds of patients presenting with severe forms will respond to antidepressant treatment and the last twenty years has witnessed a great increase in the number of these drugs. Older, frail people are particularly vulnerable to side effects. OBJECTIVES: The aims of this review were to examine the efficacy of antidepressant classes, to compare the withdrawal rates associated with each class and describe the side effect profile of antidepressant drugs for treating depression in patients described as elderly, geriatric, senile or older adults, aged 55 or over. SEARCH STRATEGY: The Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trials Register (CCDANCTR-Studies) was searched (2003-08-13). Reference lists of relevant papers and previous systematic reviews were hand searched for published reports and citations of unpublished studies. SELECTION CRITERIA: Only randomised controlled trials were included. Trials had to compare at least two active antidepressant drugs in the treatment of depression. DATA COLLECTION AND ANALYSIS: Reviewers extracted data independently. In examining efficacy, the reviewers assumed that people who died or dropped out had no improvement. Withdrawal rates irrespective of cause and specifically due to side effects were compared between drug classes. Relative risk (RR) for dichotomous data and weighted mean difference for continuous data were calculated with 95% confidence intervals (CI). Qualitative side effect data were reported in terms of ratios of side effects and percentage of patients experiencing specific side effects. MAIN RESULTS: A total of 29 trials provided data for inclusion in the review. We were unable to find any differences in efficacy when comparing classes of antidepressants. However, as the trials contained relatively small numbers of patients, these findings may be explained by a type two error. Tricyclic antidepressants (TCAs) compared less favourably with selective serotonin reuptake inhibitors (SSRIs) in terms of numbers of patients withdrawn irrespective of reason (RR: 1.24, CI 1.04, 1.47) and number withdrawn due to side effects (RR: 1.30, CI 1.02, 1.64). Subgroup analyses demonstrated that TCA related antidepressants had similar withdrawal rates to SSRIs irrespective of reason of withdrawal (RR: 1.49, CI 0.74, 2.98) or withdrawal due to side effects (RR: 1.07, CI 0.43, 2.70). The qualitative analysis of side effects showed a small increased profile of gastro-intestinal and neuropsychiatric side effects associated with classical TCAs. AUTHORS' CONCLUSIONS: Our findings suggest that SSRIs and TCAs are of the same efficacy. However, we have found some evidence suggesting that TCA related antidepressants and classical TCAs may have different side effect profiles and are associated with differing withdrawal rates when compared with SSRIs. The review suggests that classical TCAs are associated with a higher withdrawal rate due to side effect experience, although these results must be interpreted with caution due to the relatively small size of the review and the heterogeneity of the drugs and patient populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
A self-rating depression scale
ZUNG, W. W. K. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01720310065008 · Cited by 9,813 · cited 2×
“The Raskin Scale (Feighner 1985) and the Zung Depression Scale (Zung 1965) were used by Georgotas 1986; Gwirtsman 1983; Halikas 1995; Pelicier 1993.”
MethodDevelopment of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
Diagnostic Criteria for Use in Psychiatric Research
Feighner, J. P. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750190059011 · Cited by 5,715
Williams, J. W., Mulrow, C. D., Chiquette, E., Noël, P. H., Aguilar, C., & Cornell, J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-9-200005020-00011 · Cited by 423
Social Origins of Depression in Old Age
Murphy, E. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.141.2.135 · Cited by 421
Robinson, R. G., Schultz, S. K., Castillo, C., Kopel, T., Kosier, J. T., Newman, R. M., Curdue, K., Petracca, G., & Starkstein, S. E. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.351 · Cited by 384
Changes in Cognitive Functioning Following Treatment of Late-Life Depression
Butters, M. A., Becker, J. T., Nebes, R. D., Zmuda, M. D., Mulsant, B. H., Pollock, B. G., & Reynolds, C. F. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.12.1949 · Cited by 365
Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients.
Cohn, C. K., Shrivastava, R., Mendels, J., Cohn, J. B., Fabre, L. F., Claghorn, J. L., Dessain, E. C., Itil, T. M., & Lautin, A. (1990) · PubMed · Cited by 348
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.12.1735 · Cited by 285
Cited by
Treatment and prevention of mental disorders in low-income and middle-income countries
Patel, V., Araya, R., Chatterjee, S., Chisholm, D., Cohen, A., De Silva, M., Hosman, C., McGuire, H., Rojas, G., & van Ommeren, M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61240-9 · Cited by 930
Management of Depression in Older Adults: A Review
Kok, R. M., & Reynolds, C. F. (2017) · JAMA · doi:10.1001/jama.2017.5706 · Cited by 890
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011) · BMJ · doi:10.1136/bmj.d4551 · Cited by 833
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
American Geriatrics Society Expert Panel on the Care of Older Adults with Diabetes Mellitus (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12514 · Cited by 326
Citalopram versus other anti-depressive agents for depression
Cipriani, A., Purgato, M., Furukawa, T. A., Trespidi, C., Imperadore, G., Signoretti, A., Churchill, R., Watanabe, N., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006534.pub2 · Cited by 311
Clinical pharmacology in the geriatric patient
Hilmer, S. N., McLachlan, A. J., & Le Couteur, D. G. (2007) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00473.x · Cited by 296
Screening for Depression in Adult Patients in Primary Care Settings: A Systematic Evidence Review
O'Connor, E. A., Whitlock, E. P., Beil, T. L., & Gaynes, B. N. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-11-200912010-00007 · Cited by 282
Naismith, S. L., Norrie, L. M., Mowszowski, L., & Hickie, I. B. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.05.009 · Cited by 270
Depression and frailty in later life: a synthetic review
Mezuk, B., Edwards, L., Lohman, M., Choi, M., & Lapane, K. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2807 · Cited by 257
“…clear implications for efforts to treat depression in later life; although selective serotonin reuptake inhibitors are considered a first-line therapy for treating depression among older adults, there is a paucity of effectiveness data on these medications in this age group (Mottram et al., 2006).”
BackgroundThe clinical implications of ageing for rational drug therapy
Shi, S., Mörike, K., & Klotz, U. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0422-1 · Cited by 244
“This has resulted in a shift in the pattern of antidepressant use in the elderly from tricyclic antidepressants to selective serotonin reuptake inhibitors that are almost devoid of anticholinergic effects [103, 185].”
BackgroundNelson, J. C., Delucchi, K., & Schneider, L. S. (2008) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000308883.64832.ed · Cited by 230
Kok, R. M., Nolen, W. A., & Heeren, T. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.02.036 · Cited by 167
Antidepressants for the treatment of depression in people with cancer
Ostuzzi, G., Matcham, F., Dauchy, S., Barbui, C., & Hotopf, M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011006.pub3 · Cited by 158
Continuation and maintenance treatments for depression in older people
Wilkinson, P., & Izmeth, Z. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006727.pub3 · Cited by 151
Sneed, J. R., Rutherford, B. R., Rindskopf, D., Lane, D. T., Sackeim, H. A., & Roose, S. P. (2008) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181256b1d · Cited by 140
The Depression Treatment Cascade in Primary Care: A Public Health Perspective
Pence, B. W., O’Donnell, J. K., & Gaynes, B. N. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0274-y · Cited by 133
Tham, A., Jonsson, U., Andersson, G., Söderlund, A., Allard, P., & Bertilsson, G. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.013 · Cited by 104
Antidepressants for the treatment of depression in people with cancer
Vita, G., Compri, B., Matcham, F., Barbui, C., & Ostuzzi, G. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011006.pub4 · Cited by 73
Krause, M., Gutsmiedl, K., Bighelli, I., Schneider-Thoma, J., Chaimani, A., & Leucht, S. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.07.130 · Cited by 65
“…of previous reviews can be summarized as follows: several meta-analyses showed a significantly greater efficacy of various antidepressants compared to placebo in older adults, although the effect sizes varied ( Kok et al., 2012; Mottram et al., 2006; Thorlund et al., 2015; Wilson et al., 2001 ).”
Pollok, J., van Agteren, J. E., & Carson-Chahhoud, K. V. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012346.pub2 · Cited by 59
“Hickie 2011 reported that in studies of elderly participants side eHects related to TCAs were more serious than those related to SSRIs, but Mottram 2006 found withdrawal rates to be similar for participants receiving SSRIs and TCAs.”
BackgroundResultA review of the effectiveness of antidepressant medications for depressed nursing home residents
Boyce, R. D., Hanlon, J. T., Karp, J. F., Kloke, J., Saleh, A., & Handler, S. M. (2012) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.08.009 · Cited by 58
Kootker, J. A., Rasquin, S. M. C., Lem, F. C., van Heugten, C. M., Fasotti, L., & Geurts, A. C. H. (2017) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2016.10.013 · Cited by 53
Baba, H., Kito, S., Nukariya, K., Takeshima, M., Fujise, N., Iga, J., Oshibuchi, H., Kawano, M., Kimura, M., Mizukami, K., et al. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13349 · Cited by 50
“Although some studies report no difference in adverse events or discontinuation owing to adverse events among antidepressant classes,(101,102) others report that TCAs show more adverse events than SSRIs and non-TCAs.(103,106) Although there are no placebo-controlled studies of mirtazapine in elderly patients, randomiz…”
ResultContinuation and maintenance treatments for depression in older people
Wilkinson, P., & Izmeth, Z. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006727.pub2 · Cited by 43
Puhan, M. A., Vollenweider, D., Steurer, J., Bossuyt, P. M., & ter Riet, G. (2008) · BMC Medicine · doi:10.1186/1741-7015-6-28 · Cited by 38
Depression and cognitive impairment among newly admitted nursing home residents in the USA
Ulbricht, C. M., Rothschild, A. J., Hunnicutt, J. N., & Lapane, K. L. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4723 · Cited by 35
Kim, K.-H., Lee, S.-M., Paik, J.-W., & Kim, N.-S. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.02.016 · Cited by 34
Design characteristics that influence attrition in geriatric antidepressant trials: meta‐analysis
Heo, M., Papademetriou, E., & Meyers, B. S. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2211 · Cited by 18
Köster, M., Grohmann, R., Engel, R. R., Nitsche, M. A., Rüther, E., & Degner, D. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3281-8 · Cited by 18
Kim, M. J., Kim, N., Shin, D., Rhee, S. J., Park, C. H. K., Kim, H., Cho, S. J., Lee, J. W., Kim, E. Y., Yang, B., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0222791 · Cited by 8
Metadata
- Authors
- Mottram, P. G., Wilson, K., & Strobl, J. J.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2006-01-25
- Volume
- 2009
- Issue
- 1
- Pages
- CD003491-CD003491
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2104981347
- Cited by
- 287
- References
- 123
- FWCI
- 12.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.